Bristol-Myers Squibb Company
NYSE: BMY
$55.40
-$0.55 (-1.0%)
Closing Price on November 6, 2024
BMY Articles
The February 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
The January 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
There is great opportunity in healthcare. There is also quite a lot of risk. Politicians and consumers alike want lower drug prices. Patients want the best of the best options for devices,...
Published:
Last Updated:
The January 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Last Updated:
Judging by the most shorted stocks traded on the New York Stock Exchange between the December 31 and January 15 settlement dates, those sellers were looking for direction, as short interest moves...
Published:
Last Updated:
Bristol-Myers Squibb reported better-than-expected quarterly results before the markets opened on Thursday.
Published:
Last Updated:
The December 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
Thursday was a down day for the broad U.S. markets. After a fairly decent Wednesday, markets as a whole took a sharp turn downward. Perhaps a driving force from this was Apple lowering its...
Published:
Last Updated:
Apple, Bristol-Myers, Delta Air Lines, and United Continental all posted new 52-week lows on Thursday.
Published:
Last Updated:
Bristol-Myers has announced a definitive agreement to acquire rival Celgene in a cash and stock deal worth $74 billion. Celgene shareholders are scheduled to receive a 54% premium to Wednesday...
Published:
Last Updated:
The December 14 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
The November 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
24/7 Wall St. takes a look at what is coming up in the FDA calendar regarding biotech and pharmaceutical companies expecting updates to their drug pipeline or other major events for the rest of 2018.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Thursday included Alphabet, American Water, Apple, Facebook, Macy's, Southern Copper, Twitter and YY.
Published:
Last Updated:
The November 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated: